Royal Bank of Canada’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-4,000
Closed -$204K 6385
2017
Q4
$204K Hold
4,000
﹤0.01% 4411
2017
Q3
$210K Buy
+4,000
New +$201K ﹤0.01% 4481

Other funds holding CNMD

Royal Bank of Canada's CNMD Position: Q1 2026 in Review

Royal Bank of Canada increased its CONMED (CNMD) stake by 20% in Q1 2026, buying an estimated $154K and bringing the position to 22,619 shares worth $799K. The position accounts for ﹤0.01% of the portfolio, ranked #3796.

Royal Bank of Canada first reported a position in CNMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $27M in Q4 2023. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Royal Bank of Canada held 22,619 shares of CONMED worth $799K as of Q1 2026.
  • Royal Bank of Canada bought 3,790 CONMED shares in Q1 2026, an estimated $154K.
  • CONMED made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #3796 holding.
  • Royal Bank of Canada first reported a position in CONMED in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's CONMED position peaked at $27M in Q4 2023.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.